LXR-623 |
Partial Agonist of NR1H2, NR1H3
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
More...
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| NR1H2 |
|
|
| NR1H3 |
|
|
Partial Agonist
up to 2 uM
Selectivity
In Cell Selectivity Assessment
Selectivity Assessment Description:
PPAR and FXR Gal4 transactivation assays show no agonist effects for PPARα, PPARγ, PPARδ and FXR. Bi ...
Potency Cellular
In Vitro
NR1H2
Mode of Action: Partial Agonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm800799q
NR1H3
Mode of Action: Partial Agonist
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/jm800799q
In Vivo Validations
Mouse
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
7.9 h
Systemic clearance:
57 mL/min/kg
Volume of Distribution at Steady-State:
30.3 L/Kg
DOI Reference: 10.1021/jm800799q
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
5.8 h
Cmax:
633 ng/mL
Tmax:
0.5 h
Area Under the Curve::
3101 h·ng/mL
DOI Reference: 10.1021/jm800799q
Chemical Information
| Molecular Formula | C21H12ClF5N2 |
| SMILEs | Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1 |
| InChI | InChI=1S/C21H12ClF5N2/c22-18-10-15(24)9-6-13(18)11-29-20(12-4-7-14(23)8-5-12)16-2-1-3-17(19(16)28-29)21(25,26)27/h1-10H,11H2 |
| Molecular weight | 422.06 Da |
| AlogP | 6.702000000000003 |
| HBond acceptors | 2 |
| HBond donors | -- |
| Atoms | 41 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the Portal.